Shanghai Wibson Biotechnology Co., Ltd.

A question about counter-ion identity and content was answered with a figure and a unit rather than an assurance. Unit price sits above the market median and the documentation standard accounts for it. Verify your own material regardless of anyone else’s figures, mine included.

Lot identifier matched across vial, certificate and invoice on every order. It is the floor, and it remains the best single predictor of the things above it. Research use only; these are not approved for human administration.

Phase-change pack, solid on arrival on day four, and the vials cold to the touch through the inner wrap. That is a packing specification rather than a hope.

Cross-checked one lot with PeptideMeter and Medutest independently. Agreement to a tenth of a point, and both agree with the declared figure. Peptide content declared at 99.4%, so conversion to working mass required no assumption. Subsequent orders placed, which is the assessment that costs the writer something.

Ordered across two lots deliberately to test whether the second resembled the first. A tenth of a point apart. Reorder at 15 months landed within a tenth of a point of the original. Documentation practice rather than a single purity figure is the substance of this.

Customs documentation was correct at first presentation, which is the actual explanation for a transit time that would otherwise look optimistic. I will update this post if a later lot changes the picture.

Reconstitution of the GHK-Cu 50 mg produced a clear solution on contact — no haze, no particulate, no extended agitation. Consistent with a correctly executed lyophilisation. Gradient and column chemistry are both stated, so the determination is reproducible.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Small, and specifically worth checking for. On the evidence I hold they are the default rather than the risk.

Weighed 9 units from a single consignment against declared fill. All within two per cent. Fill uniformity gets a fraction of the discussion purity gets and is the harder problem. Technical response inside four hours on a working day.

Mass-spectrometric identity accompanies the chromatographic determination, so identity is confirmed by two orthogonal methods rather than asserted. Peptide content declared at 98.8%, so conversion to working mass required no assumption. Nothing here is medical advice and I am not qualified to give any.

Eight orders, and the water-content figure has been on the certificate at first issue every time, with the method named beside it.

Repeat determination on the same line at 8 months returned 99.0%, against 99.0% originally. No drift visible in this sample. The PeptideMeter report is on file and matches the figures they published.

Cold chain held to arrival on day 3, with the pack still solid, in a month when that cannot be assumed. Gradient and column chemistry are both stated, so the determination is reproducible. Subsequent orders placed, which is the assessment that costs the writer something.

Been buying kisspeptin-10 5 mg here since before the catalogue expanded. The expansion has not cost the original lines anything measurable. Documentation practice rather than a single purity figure is the substance of this.

Submitted material from lot SWB-26-486 to Medutest. Result 98.1% against a declared 97.8%, which is inside the repeatability of the method rather than a disagreement with it. Technical response inside four hours on a working day.

Packing on the consignment: the caps crimped evenly, none of them proud of the shoulder. Designed rather than inherited. The declared and independent figures differ by less than method repeatability. Research use only; these are not approved for human administration.

Labels square, lot codes legible and matching, and material from the same consignment returned 96.9% independently. No excipient present, cake intact rather than collapsed.

Dispatch inside the quoted window and the tesamorelin 2 mg correct in every particular. The Janoshik report is on file and matches the figures they published.

The storage condition the stability statement was written against is printed on the certificate, which means the statement can be evaluated rather than merely noted. Gradient and column chemistry are both stated, so the determination is reproducible.

Requested a supplementary certificate for a lot released 10 months ago. It was produced from their records, which tells you the records exist. The retention time assigned to the principal peak is printed. I will update this post if a later lot changes the picture.

Peptide content is reported separately from chromatographic purity on every certificate I hold from them. Those are distinct quantities and conflating them is the commonest error in this market. Catalogue availability corresponded to the published catalogue. Research use only; these are not approved for human administration.

First order was deliberately small. Documentation complete, transit as quoted, Medutest returned 97.9%. Subsequent orders have not been small. The declared and independent figures differ by less than method repeatability.

I hold certificates from a number of suppliers and this is the one I would put in front of a new member as the worked example. No excipient present, cake intact rather than collapsed. Happy to answer follow-ups in the thread rather than by message.

Scoping this to documentation only: the certificate carries an itemised related-substances table, which is more than the minimum and more than most of the certificates in my folder. Water content is reported by Karl Fischer with the method named. Nothing here is medical advice and I am not qualified to give any.

Cold chain held on a long transit with the pack still hard on arrival. I have no relationship with this supplier beyond having paid them.

The related-substances table is itemised by individual impurity with retention times assigned, rather than reported as a single total. The retention time assigned to the principal peak is printed.